Skip to main navigation
XBiotech USA, INC. Desktop Logo
XBiotech USA, INC. Mobile Logo
Technology
Technology
Overview
True Human™ Antibodies
Manufacturing
Pipeline
Pipeline
Overview
Anti-inflammatory Therapy
Infectious Diseases
Clinical
Clinical
Overview
Clinical Research
Publications
News
News
Press Releases
News Updates
About
About
About XBiotech
Leadership
Careers
Contact Us
Investors
Investors
Investors
Investors
Investors
Investors

Press Releases

Investor Relations
  • Overview
    Overview
  • Stock Information
    Stock Information
  • Press Releases
    Press Releases
  • Governance
    Governance
  • Financials
    Financials
  • Investor FAQ
    Investor FAQ
  • Contact Transfer Agent
    Contact Transfer Agent
XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis
IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today announced that its Investigational New Drug (IND) application for V-SPINE (PT064), a
Jun 15, 2026
PDF Version

Medicine should make you feel better, not worse

Modern medicine should help patients feel better, not worse. At XBiotech, we believe in the Hippocratic principle of "do no harm." We believe this is inherent to the innovative True Human™ antibody medicines we are developing. True Human™ antibodies move beyond the idea that effective medicines must come with toxicity or harmful side effects.

 

By utilizing the body’s natural immune system, XBiotech develops therapies that help you heal and feel better.

Contact Us
Contact Us
XBiotech USA, INC. footer logo

XBiotech’s True Human™ antibodies are derived from individuals with natural immunity to disease.

Extra links
Technology
Technology
Pipeline
Pipeline
Clinical
Clinical
News
News
About
About
Investor
Investor
Our contacts

Call:

(512) 386-2900 (512) 386-2900

Fax:

(512) 386-5505 (512) 386-5505
publicrelations@xbiotech.com publicrelations@xbiotech.com 5217 WINNEBAGO LN. AUSTIN 5217 WINNEBAGO LN. AUSTIN
Search
© XBiotech USA, INC. . All Rights Reserved 2026